Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhan Yu Pan
Observed names:
Z Pan,
Z. Pan,
Z.Y. Pan,
Zhan-yu Pan,
Zhanyu Pan,
Zichen Pan
show all 6
Institutions:
Shandong University of Traditional Chinese Medicine,
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Shandong University of Traditional Chinese Medicine,
Chinese Academy of Medical Sciences & Peking Union Medical College,
Tianjin Medical University Cancer Institute and Hospital,
Fu Wai Hospital,
Tianjin Medical University
ORCID:
0009-0009-6222-0109
Observed ORCID:
0009-0009-6222-0109
OpenAlex ID:
A5108316308
Study of the methylation patterns of the EGFR gene promoter in non-small cell lung cancer
2015
·
Z.Y. Pan
, Z.S. Jiang
, et al.
·
Genetics and Molecular Research
·
10
PDF
[Effects of oral calcium supplementation on blood pressure in population].
2000
·
Z Pan
, L Zhao
, et al.
·
PubMed
·
10
Assessing the impact of drinking water iodine concentrations on the iodine intake of Chinese pregnant women living in areas with restricted iodized salt supply
2020
·
M. Gao
, W. Chen
, et al.
·
European Journal of Nutrition
·
6
[Diagnosis and treatment of epithelioid sarcoma].
2011
·
Yan-min Xing
, Zhan-yu Pan
, et al.
·
PubMed
·
6
Comparison of effectiveness between warm acupuncture with local-distal points combination and local distribution points combination in breast cancer-related lymphedema patients: a study protocol for a multicenter, randomized, controlled clinical trial
2019
·
Chien-Hung Yeh
, Tian Yi Zhao
, et al.
·
Trials
·
4
PDF
[Progress of PD-1/PD-L1 Inhibitors in Non-small Cell Lung Cancer].
2017
·
Zhansheng Jiang
, Zhanyu Pan
, et al.
·
PubMed Central
·
2
PDF
Causal relationship between frailty and diabetes subtypes: A bidirectional Mendelian randomization study
2025
·
Zichen Pan
, Dejun Cun
, et al.
·
Medicine
WITHDRAWN: 2793eP Efficacy and safety of first-line etoposide plus anlotinib and envafolimab in elderly patients with small-cell lung cancer: An open-label, single-arm, phase II study
2025
·
J. Xu
, M. Zhang
, et al.
·
Annals of Oncology
98TiP Safety and efficacy of aumolertinib combined with anlotinib as 1st-line treatment in advanced lung cancer EGFR mutation with TP53 co-mutation
2024
·
Z. Jiang
, Z.Y. Pan
, et al.
·
ESMO Open
[A Retrospective Study of Chinese Herbal Medicine Combined with Systemic Chemotherapy and/or Regional Arterial Perfusion for Pancreatic Cancer with Liver Metastases].
2015
·
Hua-qiang Ouyang
, Zhan-yu Pan
, et al.
·
Chinese journal of integrated traditional and Western medicine
Show more works
View as search
Works count:
10
Citation count:
38
H-index:
4
I10-index:
2
Year
Topic
Type